Jefferies Group's GILD Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 163,391 shares of Gilead Sciences, Inc. (GILD) worth $20.05 M, representing 0.10% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in GILD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 401,006 shares. Largest reduction occurred in Q2 2023, reducing 227,528 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +55,180 | New Buy | 55,180 | $85.85 |
| Q1 2023 | +370,022 | Add 670.57% | 425,202 | $82.97 |
| Q2 2023 | -227,528 | Reduce 53.51% | 197,674 | $77.07 |
| Q3 2023 | +49,329 | Add 24.95% | 247,003 | $74.94 |
| Q4 2023 | -216,287 | Reduce 87.56% | 30,716 | $81.01 |
| Q1 2024 | +401,006 | Add 1305.53% | 431,722 | $73.25 |
| Q2 2024 | -110,927 | Reduce 25.69% | 320,795 | $68.61 |
| Q3 2024 | -119,519 | Reduce 37.26% | 201,276 | $83.84 |
| Q4 2024 | +18,200 | Add 9.04% | 219,476 | $92.37 |
| Q1 2025 | +44,423 | Add 20.24% | 263,899 | $112.05 |
| Q2 2025 | -200,269 | Reduce 75.89% | 63,630 | $110.87 |
| Q3 2025 | +48,900 | Add 76.85% | 112,530 | $111.00 |
| Q4 2025 | +50,861 | Add 45.20% | 163,391 | $122.74 |
Jefferies Group's Gilead Sciences Investment FAQs
Jefferies Group first purchased Gilead Sciences, Inc. (GILD) in Q4 2022, acquiring 55,180 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Gilead Sciences, Inc. (GILD) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to Gilead Sciences, Inc. (GILD) was in Q1 2024, adding 431,722 shares worth $31.62 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 163,391 shares of Gilead Sciences, Inc. (GILD), valued at approximately $20.05 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.10% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Gilead Sciences, Inc. (GILD) was 431,722 shares, as reported at the end of Q1 2024.